AATF suppresses apoptosis, promotes proliferation and is critical for Kras-driven lung cancer

Daniela Welcker1,2, Manaswita Jain1,2, Safiya Khurshid1,2,3

  • 1Department II of Internal Medicine, University of Cologne, Cologne, Germany.

Oncogene
|January 12, 2018
PubMed

Insights

Cancer cells evade DNA damage responses for tumor growth. Researchers found that AATF (che-1) sustains proliferative tissues and tumor progression by inhibiting p53-driven apoptosis, suggesting AATF as a potential drug target for KRAS-driven cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Malignant transformation involves cancer cells evading intrinsic DNA damage responses, allowing tumor progression despite accumulated DNA lesions.
  • Mechanisms underlying cancer cell tolerance to genotoxic stress remain poorly understood.
  • Replication stress is observed in Kras-driven lung adenocarcinomas and other proliferating tissues.

Purpose of the Study:

  • To investigate the mechanisms of DNA damage tolerance in cancer.
  • To identify key molecules involved in sustaining proliferative tissues and tumor progression.
  • To evaluate the therapeutic potential of targeting specific regulators in KRAS-driven malignancies.

Main Methods:

  • Analysis of replication stress in Kras-driven murine lung adenocarcinomas and proliferating tissues.
  • Identification and functional characterization of the transcriptional regulator AATF/CHE-1.
  • In vivo studies involving Aatf deletion in an autochthonous Kras-driven lung adenocarcinoma model.
  • In vivo tumor targeting of Aatf using a dual recombinase strategy.

Main Results:

  • Replication stress is a feature of Kras-driven lung adenocarcinomas and proliferating normal tissues.
  • The transcriptional regulator AATF/CHE-1 was identified as crucial for sustaining proliferative tissues and tumor progression.
  • AATF inhibits p53-driven apoptosis in vivo.
  • Aatf deletion in a Kras-driven lung cancer model delayed tumor formation in a p53-dependent manner.
  • Targeting Aatf in established tumors halted tumor progression.

Conclusions:

  • AATF/CHE-1 plays a critical role in enabling cancer cells to tolerate DNA damage and promote tumor progression.
  • AATF's inhibition of p53-driven apoptosis is key to its function in cancer.
  • AATF represents a potential therapeutic target for KRAS-driven malignancies.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
15.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
19.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Critical Region, Critical Values and Significance Level01:16

Critical Region, Critical Values and Significance Level

The critical region, critical value, and significance level are interdependent concepts crucial in hypothesis testing.
In hypothesis testing, a sample statistic is converted to a test statistic using z, t, or chi-square distribution. A critical region is an area under the curve in  probability distributions demarcated by the critical value. When the test statistic falls in this region, it suggests that the null hypothesis must be rejected. As this region contains all those values of the...
13.4K